Research on HIV cure: Mapping the ethics landscape

UNAIDS. Global AIDS Update. 2016. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.unaids.org/sites/default/files/media_asset/global-AIDS-update-2016_en.pdf" xlink:type="simple">http://www.unaids.org/sites/default/files/media_asset/global-AIDS-update-2016_en.pdf</ext-link>

UNAIDS. UNAIDS Data 2017. 2017. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.unaids.org/sites/default/files/media_asset/20170720_Data_book_2017_en.pdf" xlink:type="simple">http://www.unaids.org/sites/default/files/media_asset/20170720_Data_book_2017_en.pdf</ext-link>

SG Deeks, 2016, International AIDS Society Global Scientific Strategy: Towards an HIV Cure 2016, Nat Med, 22, 839, 10.1038/nm.4108

K Allers, 2011, Evidence for the Cure of HIV Infection by CCR5Δ32/Δ32 Stem Cell Transplantation, Blood, 117, 2791, 10.1182/blood-2010-09-309591

FDA. Backgrounder for FDA’s HIV Patient-Focused Drug Development and HIV Cure Research Public Meeting. 2013. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.fda.gov/downloads/ForIndustry/UserFees/PrescriptionDrugUserFee/UCM354549.pdf" xlink:type="simple">http://www.fda.gov/downloads/ForIndustry/UserFees/PrescriptionDrugUserFee/UCM354549.pdf</ext-link>

AS Fauci, 2014, An HIV Cure: Feasibility, Discovery, and Implementation, JAMA, 312, 335, 10.1001/jama.2014.4754

B Lo, 2013, Ethical Considerations in HIV Cure Research: Points to Consider, Curr Opin HIV AIDS, 8, 243, 10.1097/COH.0b013e32835ea1c5

MJ Khoury, 2007, The Continuum of Translation Research in Genomic Medicine: How Can We Accelerate the Appropriate Integration of Human Genome Discoveries into Health Care and Disease Prevention?, Genet Med, 9, 665, 10.1097/GIM.0b013e31815699d0

MJ Kagarise, 2000, Translational Ethics: A Perspective for the New Millennium, Arch Surg, 135, 39, 10.1001/archsurg.135.1.39

K Bærøe, 2014, Translational Ethics: An Analytical Framework of Translational Movements between Theory and Practice and a Sketch of a Comprehensive Approach, BMC Med Ethics, 15, 71, 10.1186/1472-6939-15-71

N Archin, 2014, Eradicating HIV-1 Infection: Seeking to Clear a Persistent Pathogen, Nat Rev Microbiol, 12, 750, 10.1038/nrmicro3352

N Kumar, 2016, Animal Models to Achieve an HIV Cure, Curr Opin HIV AIDS, 11, 432, 10.1097/COH.0000000000000290

HB Van Der Worp, 2010, Can Animal Models of Disease Reliably Inform Human Studies?, PLoS Med, 7

J Kimmelman, 2011, Predicting Harms and Benefits in Translational Trials: Ethics, Evidence, and Uncertainty, PLoS Med, 8, 10.1371/journal.pmed.1001010

S Festing, 2007, Talking Point on the Use of Animals in Scientific Research, EMBO Rep, 8, 526, 10.1038/sj.embor.7400993

S Joffe, 2008, Bench to Bedside. Mapping the Moral Terrain of Clinical Research, Hastings Cent Rep, 30, 10.1353/hcr.2008.0019

S Kummar, 2008, Phase 0 Clinical Trials: Conceptions and Misconceptions, Cancer J, 14, 133, 10.1097/PPO.0b013e318172d6f3

K Dubé, 2017, Perceptions of Equipoise, Risk–Benefit Ratios, and “Otherwise Healthy Volunteers” in the Context of Early-Phase HIV Cure Research in the United States: A Qualitative Inquiry, J Empir Res Hum Res Ethics, 1

F Nakagawa, 2012, Projected Life Expectancy of People with HIV According to Timing of Diagnosis, AIDS, 26, 335, 10.1097/QAD.0b013e32834dcec9

K Dubé, 2014, Framing Expectations in Early HIV Cure Research, Trends Microbiol, 22, 547, 10.1016/j.tim.2014.08.003

GE Henderson, 2014, The Ethics of HIV “Cure” Research: What Can We Learn from Consent Forms?, AIDS Res Hum Retroviruses, 31, 1

DM Margolis, 2013, Combined Approaches for HIV Cure, Curr Opin HIV AIDS, 8, 230, 10.1097/COH.0b013e32835ef089

K Dubé, 2017, “Well, It&apos;s the Risk of the Unknown… Right?’: A Qualitative Study of Perceived Risks and Benefits of HIV Cure Research in the United States, PLoS ONE, 12, 10.1371/journal.pone.0170112

U.S. DHHS. The Belmont Report. Ethical Principles and Guidelines for the Protection of Human Subjects of Research. In: The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. 1979. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.html" xlink:type="simple">http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.html</ext-link>

S Gianella, 2016, Barriers to a Cure for HIV in Women, J Int AIDS Soc, 19, 1, 10.7448/IAS.19.1.20706

MJ Curno, 2016, A Systematic Review of the Inclusion (or Exclusion) of Women in HIV Research: from Clinical Studies of Antiretrovirals and Vaccines to Cure Strategies, JAIDS, 71, 181

B Brown, 2016, Transparency of Participant Incentives in HIV Research, Lancet HIV, 3, e456, 10.1016/S2352-3018(16)30150-3

T Rossouw, 2017, Barriers to HIV Remission Research in Low- and Middle-Income Countries, J Int AIDS Soc, 20, 1, 10.7448/IAS.20.1.21521

R Brown, 2017, The Social Value of Candidate HIV Cures: Actualism versus Possibilism, J Med Ethics, 43, 118, 10.1136/medethics-2015-103125

Treatment Action Group (TAG). Research Toward a Cure Trials. 2017. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.treatmentactiongroup.org/cure/trials" xlink:type="simple">http://www.treatmentactiongroup.org/cure/trials</ext-link>

SK Shah, 2017, When to Start Paediatric Testing of the Adult HIV Cure Research Agenda?, J Med Ethics, 43, 82, 10.1136/medethics-2015-103116

J Sugarman, 2016, Ethics of ART Interruption after Stem-Cell Transplantation, Lancet HIV, 3, e8, 10.1016/S2352-3018(15)00248-9

SA Garner, 2017, Interrupting Antiretroviral Treatment in HIV Cure Research: Scientific and Ethical Considerations, J Virus Erad, 3, 82, 10.1016/S2055-6640(20)30287-9

K Dubé, 2017, “We Need to Deploy Them Very Thoughtfully and Carefully”: Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States, AIDS Res Hum Retroviruses

Forum for Collaborative HIV Research. Regulatory Pathway for HIV Cure Research: Developing Consensus Part 1. 2014. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.hivforum.org/storage/documents/2014/HIVCure/forum_hiv_cureproject_june17th_meeting_agenda.pdf" xlink:type="simple">http://www.hivforum.org/storage/documents/2014/HIVCure/forum_hiv_cureproject_june17th_meeting_agenda.pdf</ext-link>

JZ Li, 2015, The Need for Treatment Interruption Studies and Biomarker Identification in the Search for an HIV Cure, AIDS, 29, 1429, 10.1097/QAD.0000000000000658

J Tucker, 2014, Words Matter: Discussing Research towards an HIV Cure in Research and Clinical Contexts, JAIDS J Acquir Immune Defic Syndr, 67, 110, 10.1097/QAI.0000000000000305

M Lederman, 2016, A Cure for HIV Infection: “Not in My Lifetime” or “Just Around the Corner”?, Pathog Immun, 1, 154, 10.20411/pai.v1i1.133

DR Kuritzkes, 2016, Why Cure, Why Now?, J Med Ethics, 1

K Dubé, 2017, Willingness to Participate and Take Risks in HIV Cure Research: Survey Results from 400 People Living with HIV in the US, J Virus Erad, 3, 40, 10.1016/S2055-6640(20)30295-8

KM MacQueen, 2005, The Multiple Layers of Prevention Science Research, Am J Prev Med, 28, 491, 10.1016/j.amepre.2005.02.020

KM MacQueen, 2001, What is Community? An Evidence-Based Definition for Participatory Public Health, Am J Public Health, 91, 1929, 10.2105/AJPH.91.12.1929

ZC Rich, 2015, Physician Perceptions of HIV Cure in China: A Mixed Methods Review and Implications for HIV Cure Research, Asian Pacific J Trop Dis, 5, 687, 10.1016/S2222-1808(15)60913-6

B Brown, 2016, Barriers to Routine HIV Testing in Healthcare Settings and Potential Solutions from the Get Tested Coachella Valley Campaign, J Acquir Immune Defic Syndr, 71, 127, 10.1097/QAI.0000000000000911

2015, Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection, N Engl J Med, 373, 795, 10.1056/NEJMoa1506816

O Bhattacharyya, 2009, What is Implementation Research?, Res Soc Work Pract, 19, 491, 10.1177/1049731509335528

IL Shytaj, 2013, A Cure for AIDS: A Matter of Timing?, Retrovirology, 10, 145, 10.1186/1742-4690-10-145

JE Adair, 2016, Semi-Automated Closed System Manufacturing of Lentivirus Gene-Modified Haematopoietic Stem Cells for Gene Therapy, Nat Commun, 7, 13173, 10.1038/ncomms13173

I Sereti, 2015, Towards a Scalable HIV Cure Research Agenda: The Role of Co-Infections, J Virus Erad, 1, 269, 10.1016/S2055-6640(20)30925-0

TJ Henrich, 2017, HIV-1 Persistence Following Extremely Early Initiation of Antiretroviral Therapy (ART) during Acute HIV-1 Infection: An Observational Study, PLoS Med, 14, e1002417, 10.1371/journal.pmed.1002417

K Moodley, 2016, Synergies, Tensions and Challenges in HIV Prevention, Treatment and Cure Research: Exploratory Conversations with HIV Experts in South Africa. BMC Med Ethics, BMC Medical Ethics, 17, 26, 10.1186/s12910-016-0109-1